Skip to main content
Top
Published in: Clinical Rheumatology 6/2006

01-11-2006 | Original Article

Bcl-xL expression in vivo in rheumatoid synovium

Authors: S. Busteed, M. W. Bennett, C. Molloy, A. Houston, M. A. Stone, F. Shanahan, M. G. Molloy, J. O’Connell

Published in: Clinical Rheumatology | Issue 6/2006

Login to get access

Abstract

To examine the expression of the apoptosis regulatory protein, Bcl-xL, in the synovium of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Immunohistochemistry for Bcl-xL was carried out on synovial samples from patients with RA and OA. Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot analysis were performed to qualitatively examine the expression of Bcl-xL. Bcl-xL expression was detected in the lining, endothelium and inflammatory cells of both RA (n=20) and OA (n=10) samples. However, there was significantly more expression in the lining of RA synovium compared to OA (77 vs 61%, p<0.05). Many of the positive cells in the RA subsynovium were noted to be plasma cells. There was a significant correlation between Bcl-xL expression and the number of inflammatory cells in the subsynovium of RA and OA patients (r s=0.376, p<0.05, n=30). Age and disease duration did not correlate with Bcl-xL expression in rheumatoid patients. Bcl-xL may play a role in the extended survival of synoviocytes and inflammatory cells in rheumatoid synovium.
Literature
1.
go back to reference Yamamura Y, Gupta R, Morita Y et al (2001) Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166:2270–2275PubMed Yamamura Y, Gupta R, Morita Y et al (2001) Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166:2270–2275PubMed
2.
go back to reference Zvaifler NJ, Boyle D, Firestein GS (1994) Early synovitis-synoviocytes and mononuclear cells. Semin Arthritis Rheum 23:11–16CrossRefPubMed Zvaifler NJ, Boyle D, Firestein GS (1994) Early synovitis-synoviocytes and mononuclear cells. Semin Arthritis Rheum 23:11–16CrossRefPubMed
3.
go back to reference Rudin CM, Thompson CB (1997) Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 48:267–281CrossRefPubMed Rudin CM, Thompson CB (1997) Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 48:267–281CrossRefPubMed
4.
go back to reference Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed
5.
go back to reference Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449–1456PubMed Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449–1456PubMed
6.
go back to reference Nakajima T, Aono H, Hasunuma T et al (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485–491PubMed Nakajima T, Aono H, Hasunuma T et al (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485–491PubMed
7.
go back to reference Firestein GS, Yeo M, Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631–1638PubMed Firestein GS, Yeo M, Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631–1638PubMed
8.
go back to reference Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899–1911PubMed Gross A, McDonnell JM, Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899–1911PubMed
9.
go back to reference Basanez G, Zhang J, Chau BN et al (2001) Pro-apoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J Biol Chem 276:31083–31091CrossRefPubMed Basanez G, Zhang J, Chau BN et al (2001) Pro-apoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J Biol Chem 276:31083–31091CrossRefPubMed
10.
go back to reference Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s–1700sPubMed Korsmeyer SJ (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s–1700sPubMed
11.
go back to reference Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K 3rd, Pope RM (2000) Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–5235PubMed Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K 3rd, Pope RM (2000) Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–5235PubMed
12.
go back to reference Kharbanda S, Pandey P, Schofield L et al (1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A 94:6939–6942CrossRefPubMed Kharbanda S, Pandey P, Schofield L et al (1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A 94:6939–6942CrossRefPubMed
13.
go back to reference Fang W, Weintraub BC, Dunlap B et al (1998) Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity 9:35–45CrossRefPubMed Fang W, Weintraub BC, Dunlap B et al (1998) Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity 9:35–45CrossRefPubMed
14.
go back to reference Bovia F, Nabili-Tehrani AC, Werner-Favre C, Barnet M, Kindler V, Zubler RH (1998) Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels. Eur J Immunol 28:4418–4423CrossRefPubMed Bovia F, Nabili-Tehrani AC, Werner-Favre C, Barnet M, Kindler V, Zubler RH (1998) Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels. Eur J Immunol 28:4418–4423CrossRefPubMed
15.
go back to reference Hayashida K, Shimaoka Y, Ochi T, Lipsky PE (2000) Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 164:1110–1116PubMed Hayashida K, Shimaoka Y, Ochi T, Lipsky PE (2000) Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 164:1110–1116PubMed
16.
go back to reference Zhang X, Li L, Choe J et al (1996) Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 173:149–154CrossRefPubMed Zhang X, Li L, Choe J et al (1996) Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 173:149–154CrossRefPubMed
17.
go back to reference Lakics V, Medvedev AE, Okada S, Vogel SN (2000) Inhibition of LPS-induced cytokines by Bcl-xL in a murine macrophage cell line. J Immunol 165:2729–2737PubMed Lakics V, Medvedev AE, Okada S, Vogel SN (2000) Inhibition of LPS-induced cytokines by Bcl-xL in a murine macrophage cell line. J Immunol 165:2729–2737PubMed
18.
go back to reference Lindblad S, Hedfors E (1985) Intraarticular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis Rheum 28:977–986PubMed Lindblad S, Hedfors E (1985) Intraarticular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis Rheum 28:977–986PubMed
19.
go back to reference Yamanishi Y, Firestein GS (2001) Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 27:355–371CrossRefPubMed Yamanishi Y, Firestein GS (2001) Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 27:355–371CrossRefPubMed
20.
go back to reference Mountz JD, Hsu H, Matsuki Y, Zhang H (2001) Apoptosis and rheumatoid arthritis: past, present, and future directions. Curr Rheumatol Rep 3:70–78PubMed Mountz JD, Hsu H, Matsuki Y, Zhang H (2001) Apoptosis and rheumatoid arthritis: past, present, and future directions. Curr Rheumatol Rep 3:70–78PubMed
21.
go back to reference Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352PubMed Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352PubMed
22.
go back to reference Dechanet J, Merville P, Durand I, Banchereau J, Miossec P (1995) The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 95:456–463PubMedCrossRef Dechanet J, Merville P, Durand I, Banchereau J, Miossec P (1995) The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 95:456–463PubMedCrossRef
23.
go back to reference Perry ME, Mustafa Y, Wood SK, Cawley MI, Dumonde DC, Brown KA (1997) Binucleated and multinucleated forms of plasma cells in synovia from patients with rheumatoid arthritis. Rheumatol Int 17:169–174CrossRefPubMed Perry ME, Mustafa Y, Wood SK, Cawley MI, Dumonde DC, Brown KA (1997) Binucleated and multinucleated forms of plasma cells in synovia from patients with rheumatoid arthritis. Rheumatol Int 17:169–174CrossRefPubMed
24.
go back to reference Berek C, Kim HJ (1997) B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol 9:261–268CrossRefPubMed Berek C, Kim HJ (1997) B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol 9:261–268CrossRefPubMed
25.
go back to reference Reparon-Schuijt CC, van Esch WJ, van Kooten C, Levarht EW, Breedveld FC, Verweij CL (1998) Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum 41:2211–2220CrossRefPubMed Reparon-Schuijt CC, van Esch WJ, van Kooten C, Levarht EW, Breedveld FC, Verweij CL (1998) Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum 41:2211–2220CrossRefPubMed
26.
go back to reference Drossaers-Bakker KW, Zwinderman AH, Vlieland TP et al (2002) Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 47:383–390CrossRefPubMed Drossaers-Bakker KW, Zwinderman AH, Vlieland TP et al (2002) Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 47:383–390CrossRefPubMed
27.
go back to reference Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ (2002) Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 46:906–912CrossRefPubMed Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ (2002) Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 46:906–912CrossRefPubMed
28.
go back to reference Di Girolamo N, Visvanathan K, Lloyd A, Wakefield D (1997) Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol 61:667–678PubMed Di Girolamo N, Visvanathan K, Lloyd A, Wakefield D (1997) Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol 61:667–678PubMed
29.
go back to reference Tu Y, Renner S, Xu F et al (1998) BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 58:256–262PubMed Tu Y, Renner S, Xu F et al (1998) BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 58:256–262PubMed
30.
go back to reference Sioud M, Mellbye O, Forre O (1998) Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 16:125–134PubMed Sioud M, Mellbye O, Forre O (1998) Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 16:125–134PubMed
31.
go back to reference Hilbers I, Hansen T, Petrow PK et al (2003) Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium. Rheumatol Int 23:75–81PubMed Hilbers I, Hansen T, Petrow PK et al (2003) Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium. Rheumatol Int 23:75–81PubMed
Metadata
Title
Bcl-xL expression in vivo in rheumatoid synovium
Authors
S. Busteed
M. W. Bennett
C. Molloy
A. Houston
M. A. Stone
F. Shanahan
M. G. Molloy
J. O’Connell
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0191-0

Other articles of this Issue 6/2006

Clinical Rheumatology 6/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.